Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Ali

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of the Egyptian Society of Parasitology|April 1, 1991
Cryptosporidiosis among children attending the Maternity and Paediatrics Teaching Hospital, Wad Medani, Central Region, SudanK M Hassan, F E Ali, M A Bella
Research in Developmental Disabilities|July 30, 1999
Treatment of hyperthyroidism in Down syndrome: case report and review of the literatureF E Ali, W A al-Busairi, F A al-Mulla
Molecular Diversity|June 1, 2001
Regioselective alkylation at the N4 position of a 3-oxo-1,4-benzodiazepine on solid supportF E Ali, C C Yuan, S T Ross, et al.
Journal of Medicinal Chemistry|October 1, 1982
Imidodisulfamides. 2. Substituted 1,2,3,4-tetrahydroisoquinolinylsulfonic imides as antagonists of slow-reacting substance of anaphylaxisF E Ali, J G Gleason, D T Hill, et al.
Journal of Medicinal Chemistry|August 1, 1982
Imidodisulfamides. 1. A novel class of antagonists of slow-reacting substance of anaphylaxisF E Ali, P A Dandridge, J G Gleason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysisM A Horton, E L Dorey, S A Nesbitt, et al.
Thrombosis Research|July 15, 1994
The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonistA J Nichols, J A Vasko, R E Valocik, et al.
Journal of Medicinal Chemistry|June 1, 1986
Potent vasopressin antagonists lacking the proline residue at position 7F E Ali, W Bryan, H L Chang, et al.
Journal of Medicinal Chemistry|December 1, 1987
Potent vasopressin antagonists modified at the carboxy-terminal tripeptide tailF E Ali, H L Chang, W F Huffman, et al.
Journal of Medicinal Chemistry|May 1, 1985
Orally active and potent inhibitors of gamma-aminobutyric acid uptakeF E Ali, W E Bondinell, P A Dandridge, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the Egyptian Society of Parasitology|April 1, 1991
Cryptosporidiosis among children attending the Maternity and Paediatrics Teaching Hospital, Wad Medani, Central Region, SudanK M Hassan, F E Ali, M A Bella
Research in Developmental Disabilities|July 30, 1999
Treatment of hyperthyroidism in Down syndrome: case report and review of the literatureF E Ali, W A al-Busairi, F A al-Mulla
Molecular Diversity|June 1, 2001
Regioselective alkylation at the N4 position of a 3-oxo-1,4-benzodiazepine on solid supportF E Ali, C C Yuan, S T Ross, et al.
Journal of Medicinal Chemistry|October 1, 1982
Imidodisulfamides. 2. Substituted 1,2,3,4-tetrahydroisoquinolinylsulfonic imides as antagonists of slow-reacting substance of anaphylaxisF E Ali, J G Gleason, D T Hill, et al.
Journal of Medicinal Chemistry|August 1, 1982
Imidodisulfamides. 1. A novel class of antagonists of slow-reacting substance of anaphylaxisF E Ali, P A Dandridge, J G Gleason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysisM A Horton, E L Dorey, S A Nesbitt, et al.
Thrombosis Research|July 15, 1994
The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonistA J Nichols, J A Vasko, R E Valocik, et al.
Journal of Medicinal Chemistry|June 1, 1986
Potent vasopressin antagonists lacking the proline residue at position 7F E Ali, W Bryan, H L Chang, et al.
Journal of Medicinal Chemistry|December 1, 1987
Potent vasopressin antagonists modified at the carboxy-terminal tripeptide tailF E Ali, H L Chang, W F Huffman, et al.
Journal of Medicinal Chemistry|May 1, 1985
Orally active and potent inhibitors of gamma-aminobutyric acid uptakeF E Ali, W E Bondinell, P A Dandridge, et al.
Pageof 2